A Borque Fernando - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

A Borque Fernando

Showing results (21-30 of 26) with videos related to

Pageof 3

Sort By:

You have reached the last page of results.This site can display upto 26 results.

Actas Urologicas Espanolas|September 30, 2000

[Prostatic rebiopsy. Prognosis factors of the anatomopathologic result]P Gil Martínez, C Allepuz Losa, M J Gil Sanz, et al.

Actas Urologicas Espanolas|November 1, 2024

Optimizing triple therapy in patients with metastatic hormone-sensitive prostate cancerA Borque-Fernando, D A Pérez-Fentes, M Rodrigo-Aliaga, et al.

Actas Urologicas Espanolas|June 10, 2023

Abiraterone in low-volume metastatic hormone-sensitive prostate cancer. Authors' replyA Borque-Fernando, M A Calleja-Hernández, J M Cózar-Olmo, et al.

Actas Urologicas Espanolas|January 31, 2023

A multidisciplinary consensus statement on the optimal pharmacological treatment for metastatic hormone-sensitive prostate cancerA Borque-Fernando, M A Calleja-Hernández, J M Cózar-Olmo, et al.

Actas Urologicas Espanolas|May 26, 2026

Improving Long-Term Monitoring in NMIBC: Digital Uromonitor® (dUM) as a Complementary Tool to Cystoscopy for Two-Year Recurrence Risk StratificationJ Rubio-Briones, F Guerrero Ramos, A Mercadé Sánchez, et al.

Cancer Medicine|September 10, 2025

Real World Evidence of Active Surveillance for Prostate Cancer in Spain; Midterm ResultsJ Rubio-Briones, A Borque-Fernando, L M Esteban Escaño, et al.

Pageof 3

Search research articles

Showing results (21-30 of 26) with videos related to

Sort By:

Pageof 3

You have reached the last page of results.This site can display upto 26 results.

Actas Urologicas Espanolas|September 30, 2000

[Prostatic rebiopsy. Prognosis factors of the anatomopathologic result]P Gil Martínez, C Allepuz Losa, M J Gil Sanz, et al.

Actas Urologicas Espanolas|November 1, 2024

Optimizing triple therapy in patients with metastatic hormone-sensitive prostate cancerA Borque-Fernando, D A Pérez-Fentes, M Rodrigo-Aliaga, et al.

Actas Urologicas Espanolas|June 10, 2023

Abiraterone in low-volume metastatic hormone-sensitive prostate cancer. Authors' replyA Borque-Fernando, M A Calleja-Hernández, J M Cózar-Olmo, et al.

Actas Urologicas Espanolas|January 31, 2023

A multidisciplinary consensus statement on the optimal pharmacological treatment for metastatic hormone-sensitive prostate cancerA Borque-Fernando, M A Calleja-Hernández, J M Cózar-Olmo, et al.

Actas Urologicas Espanolas|May 26, 2026

Cancer Medicine|September 10, 2025

Real World Evidence of Active Surveillance for Prostate Cancer in Spain; Midterm ResultsJ Rubio-Briones, A Borque-Fernando, L M Esteban Escaño, et al.

Pageof 3